Bacterial exopolysaccharide based magnetic nanoparticles: A versatile nanotool for cancer cell imaging, targeted drug delivery and synergistic effect of drug and hyperthermia mediated cancer therapy

Journal of Biomedical Nanotechnology

Volumn 10, Issue 6, 2014, Pages 885-899

  Sivakumar, Balasubramanian ^a   Aswathy, Ravindran Girija ^a   Sreejith, Raveendran ^a   Nagaoka, Yutaka ^a   Iwai, Seiki ^a   Suzuki, Masashi ^a   Fukuda, Takahiro ^a   Hasumura, Takashi ^a   Yoshida, Yasuhiko ^a   Maekawa, Toru ^a   Sakthikumar, Dasappan Nair ^a  

^a TOYO UNIVERSITY   (Japan)

Author keywords

Gellan gum; Magnetic hyperthermia; Magnetic nanoparticles; Mauran; Microbial exopolysaccharides; Multifunctional

Indexed keywords

BIOCOMPATIBILITY; CELLS; DRUG DELIVERY; FUNCTIONAL POLYMERS; METABOLITES; POLYSACCHARIDES;

EXOPOLYSACCHARIDES; GELLAN GUM; MAGNETIC HYPERTHERMIA; MAGNETIC NANO-PARTICLES; MAURAN; MULTIFUNCTIONAL;

NANOPARTICLES;

BACTERIAL POLYSACCHARIDE; FLUOROURACIL; FOLIC ACID; GELLAN; GELLAN MAGNETIC NANOPARTICLE; MAGNETIC NANOPARTICLE; MAURAN MAGNETIC NANOPARTICLE; NANOCOMPOSITE; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BREAST ADENOCARCINOMA; CANCER CELL; CANCER THERAPY; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPERTHERMIC THERAPY; INTERNALIZATION; MAGNETIC HYPERTHERMIA;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CELL TRACKING; COMBINED MODALITY THERAPY; DRUG SYNERGISM; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; MAGNETITE NANOPARTICLES; MICE; MOLECULAR TARGETED THERAPY; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; POLYSACCHARIDES, BACTERIAL; TREATMENT OUTCOME;

EID: 84898444023     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1820     Document Type: Article

References (62)

1. C. Zandonella, Cell nanotechnology: The tiny toolkit. Nature 423, 10 (2003).
2. J. L. West and N. J. Halas, Applications of nanotechnology to biotechnology: Commentary. Curr. Opin. Biotechnol. 11, 215 (2000).
3. J. Kreuter, Nanoparticulate systems for brain delivery of drugs. Adv. Drug Delivery Rev. 47, 65 (2001).
4. L. E. V. Vlerken and M. M. Amiji, Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin. Drug Deliv. 3, 205 (2006).
5. G. Han, P. Ghosh, and V. M. Rotello, Functionalized gold nanoparticles for drug delivery. Nanomedicine 2, 113 (2007).
6. S. Shukla, A. Priscilla, M. Banerjee, R. R. Bhonde, J. Ghatak, P. V. Satyam, and M. Sastry, Porous gold nanospheres by controlled transmetalation reaction: A novel material for application in cell imaging. Chem. Mater. 17, 5000 (2005).
7. P. Alivisatos, The use of nanocrystals in biological detection. Nat. Biotechnol. 22, 47 (2004).
8. W. C. W. Chan and S. Nie, Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016 (1998).
9. T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky, and V. Labhasetwar, Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2, 194 (2005).
10. M. Zhao, M. F. Kircher, L. Josephson, and R. Weissledre, Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug. Chem. 13, 840 (2002).
11. J. P. Butler and S. M. Kelly, A model for cytoplasmic rheology consistent with magnetic twisting cytometry. Biorheology 35, 193 (1998).
12. I. Hilger, K. Fruhauf, W. Andra, R. Hiergeist, R. Hergt, and W. A. Kaiser, Heating potential of iron oxides for therapeutic purposes in interventional radiology. Acad. Radiol. 9, 198 (2002).
13. J. W. M. Bulte, T. Douglas, B. Witwer, S. C. Zhang, E. Strable, B. K. Lewis, H. Zywicke, B. Miller, P. van Gelderen, B. M. Moskowitz, I. D. Duncan, and J. A. Frank, Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 19, 1141 (2001).
14. D. Dressman, H. Yan, G. Traverso, K. W. Kinzler, and B. Vogelstein, Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. PNAS 100, 8817 (2003).
15. R. E. Zigeuner, R. Riesenberg, H. Pohla, A. Hofstetter, and R. Oberneder, Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro. J. Urol. 169, 701 (2003).
16. A. Akbarzadeh, M. Samiei, and S. Davaran, Magnetic nanoparticles: Preparation, physical properties, and applications in biomedicine. Nanoscale Res. Lett. 144, 1 (2012).
17. M. V. Yigit, A. Moore, and Z. Medarova, Magnetic nanoparticles for cancer diagnosis and therapy. Pharm. Res. 29, 1180 (2012).
18. R. G. Aswathy, B. Sivakumar, D. Brahatheeswaran, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Multifunctional biocompatible fluorescent carboxymethyl cellulose nanoparticles. J. Biomater. Nanobiotechnol. 3, 254 (2012).
19. R. G. Aswathy, B. Sivakumar, D. Brahatheeswaran, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Green synthesis, characterization and in vitro biocompatibility of starch capped PbSe nanoparticles. Adv. Sci. Lett. 16, 69 (2012).
20. R. G. Aswathy, B. Sivakumar, D. Brahatheeswaran, T. Fukuda, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application. Adv. Nat. Sci. Nanosci. Nanotechnol. 3, 025006 (2012).
21. R. G. Aswathy, B. Sivakumar, T. Ukai, D. Brahatheeswaran, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Biocompatible luminescent jelly quantumdots for bioimaging. Materials Express 1, 291 (2011).
22. B. Sivakumar, R. G. Aswathy, Y. Nagaoka, M. Suzuki, T. Fukuda, Y. Yoshida, T. Maekawa, and D. N. Sakthikumar, Multifunctional Carboxymethyl cellulose based magnetic nanovector as theragnostic system for folate receptor targeted chemotherapy, imaging and hyperthermia against cancer. Langmuir 29, 3453 (2013).
23. A. Petri-Fink, B. Steitz, A. Finka, J. Salaklang, and H. Hofmann, Effect of cell media on polymer coated superparamagnetic iron oxide nanoparticles (SPIONs): Colloidal stability, cytotoxicity, and cellular uptake studies. Eur. J. Pharm. Biopharm. 68, 129 (2008).
24. S. Mornet, S. Vasseur, F. Grasset, and E. Duguet, Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14, 2161 (2004).
25. M. S. Arad and O. Levy-Ontman, Red microalgal cell-wall polysaccharides: Biotechnological aspects. Curr. Opin. Biotechnol. 21, 358 (2010).
26. T. Xu, N. Zhang, H. L. Nichols, D. Shi, and X. Wen, Modification of nanostructured materials for biomedical applications. Mater. Sci. Eng. C 27, 579 (2007).
27. T. Toshihiko, C. Amornrut, and J. L. Robert, Structure and bioactivity of sulfated polysaccharides. Trends Glycosci. Glyc. 15, 29 (2003).
28. S. Arias, A. D. Moral, M. R. Ferrer, R. Tallon, E. Quesada, and V. Bejar, Mauran, an exopolysaccharides produced by the halophilic bacterium Halomonas maura, with a novel composition and interesting properties for biotechnology. Extremophiles 7, 319 (2003).
29. I. Llamas, A. D. Moral, F. Martinez-Checa, Y. Arco, S. Arias, and E. Quesada, Halomonas maura is a physiologically versatile bacterium of both ecological and biotechnological interest. Antonie van Leeuwenhoek 89, 395 (2006).
30. R. Sreejith, C. P. Aby, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Bacterial exopolysaccharide based nanoparticles for sustained drug delivery, cancer chemotherapy and bioimaging. Carbohyd. Polym. 91, 22 (2013).
31. R. Sreejith, D. Brahatheeswaran, Y. Nagaoka, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Biocompatible nanofibers based on extremophilic bacterial polysaccharide, Mauran from Halomonas Maura. Carbohyd. Polym. 92, 1225 (2013).
32. R. Sreejith, Y. Yoshida, T. Maekawa, and D. Sakthi Kumar, Pharmaceutically versatile sulfated polysaccharide based bionano platforms. Nanomed. Nanotechnol. 9, 605 (2013).
33. M. A. O'Neill, R. R. Selvendran, and V. J. Morris, Structure of the acidic extracellular gelling polysaccharide produced by Pseudomonas elodea. Carbohydr. Res. 124, 123 (1983).
34. P. E. Jansson, B. Lindberg, and P. A. Sandford, Structural studies of gellan gum, an extracellular polysaccharide elaborated by Pseudomonas elodea. Carbohydr. Res. 124, 135 (1982).
35. S. Dhar, E. M. Reddy, A. Shiras, V. Pokharkar, and B. L. Prasad, Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations. Chem. Eur. J. 14, 10244 (2008).
36. J. Pan and S. S. Feng, Targeting and imaging cancer cells by folate decorated quantum dots loaded nanoparticle of biodegradable polymers. Biomaterial 30, 1176 (2009).
37. 2. Macromol. Rapid. Commun. 27, 1254 (2006).
38. Y. W. Cho, J. R. Lee, and S. C. Song, Novel thermosensitive 5-fluorouracil-cyclotriphosphazeneconjugates: Synthesis, thermosensitivity, degradability, and in vitro antitumor activity. Bioconjug. Chem. 16, 1529 (2005).
39. S. Mohapatra, D. Pal, S. K. Ghosh, and P. Pramanik, Design of superparamagnetic iron oxide nanoparticle for purification of recombinant proteins. J. Nanosci. Nanotechnol. 7, 1 (2007).
40. S. Lefebure, E. Bubois, V. Cabuil, S. Neveu, and R. Massart, Monodisperse magnetic nanoparticles: Preparation and dispersion in water and oils. J. Mater. Res. 13, 2975 (1998).
41. F. Delie, Evaluation of nano and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34, 221 (1998).
42. R. M. Young, J. K. Arnette, D. A. Roess, and B. G. Barisas, Quantitation of fluorescence energy transfer between cell surface proteins via fluorescence donor photobleaching kinetics. Biophys. J. 67, 881 (1994).
43. A. Imhof, M. Megens, J. J. Engelberts, D. T. N. Lang, R. Sprik, and W. L. Vos, Spectroscopy of fluorescein (FITC) dyed colloidal silica spheres. J. Phys. Chem. B 103, 1408 (1999).
44. A. N. Lazaro, L. Sevilla, S. Morales, and A. M. Marques, Heavy metal biosorption by gellan gum gel beads. Water Res. 37, 2118 (2003).
45. E. Fourest and B. Volesky, Alginate properties and heavy metal biosorption by marine algae. Appl. Biochem. Biotechnol. 61, 33 (1997).
46. J. L. Geddie and I. W. Sutherland, Uptake of metals by bacterial polysaccharides. J. Appl. Bacteriol. 74, 467 (1993).
47. D. H. Kim, S. H. Lee, K. H. Im, K. N. Kim, K. M. Kim, I. B. Shim, M. H. Lee, and Y. K. Lee, Surface-modified magnetite nanoparticles for hyperthermia: Preparation, characterization, and cytotoxicity studies. Curr. Appl. Phys. 6, 242 (2006).
48. E. Gomez-Ordonez and P. Ruperez, FTIR-ATR spectroscopy as a tool for polysaccharide identification in edible brown and red seaweeds. Food Hydrocolloids 25, 1514 (2011).
49. A. Dev, N. S. Binulal, A. Anitha, S. V. Nair, T. Furuike, H. Tamura, and R. Jayakumar, Preparation of poly(lactic acid)/chitosan nanoparticles for anti-HIV drug delivery applications. Carbohyd. Polym. 80, 833 (2010).
50. D. F. Coutinho, S. Sant, H. Shin, J. T. Oliveira, M. E. Gomes, N. M. Neves, A. Khademhosseini, and R. L. Reis, Modified gellan gum hydrogels with tunable physical and mechanical properties. Biomaterials 31, 7494 (2010).
51. J. Zhang, S. Rana, R. S. Srivastava, and R. D. K. Misra, On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol functionalized magnetic nanoparticles. Acta Biomater. 4, 40 (2008).
52. A. K. Gupta and S. Wells, Surface modified superparamagnetic nanoparticles for drug delivery: Preparation, characterisation and cytotoxicity studies. IEEE. Trans. Nanobiosci. 3, 66 (2003).
53. L. Zhu, J. Ma, N. Jia, Y. Zhao, and H. Shen, Chitosan coated magnetic nanoparticles as carriers of 5-Fluorouracil: Preparation, characterization and cytotoxicity studies. Colloids Surf. B 68, 1 (2009).
54. S. Vasiliu, S. Racovita, V. Neagu, M. Popa, and J. Desbrieres, Polymer-metal complexes based on gellan. Polimery 55, 839 (2010).
55. S. Zhou, X. Deng, and X. Li, Investigation on a novel core-coated microspheres protein delivery system. J. Control Release 75, 27 (2001).
56. C. Goncalves, P. Pereira, and M. Gama, Self-assembled hydrogel nanoparticles for drug delivery applications. Materials 3, 1420 (2010).
57. J. S. Kim, T. J. Yoon, K. N. Yu, M. S. Noh, M. Woo, B. G. Kim, K. H. Lee, and M. H. Cho, Cellular uptake of magnetic nanoparticle is mediated through energy dependent endocytosis in A549 cells. J. Vet. Sci. 7, 321 (2006).
58. 3 synthesized by a single step process. J. Mater. Chem. 17, 5042 (2007).
59. H. L. Rodríguez-Luccioni, M. Latorre-Esteves, J. Méndez-Vega, O. Soto, A. R. Rodríguez, C. Rinaldi, and M. Torres-Lugo, Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomedicine 6, 373 (2011).
60. L. Asín, M. R. Ibarra, A. Tres, and G. F. Goya, Controlled cell death by magnetic hyperthermia: Effects of exposure time, field amplitude, and nanoparticle concentration. Pharm. Res. 29, 1319 (2012).
61. S. Y. Hwang, S. H. Cho, B. H. Lee, Y. L. Song, and E. K. Lee, Cellular imaging assay for early evaluation of an apoptosis inducer. Apoptosis 16, 1068 (2011).
62. M. P. Garcia, J. R. Cavalheiro, and M. H. Fernandes, Acute and long-term effects of hyperthermia in B16-F10 melanoma cells. PLoS One 7, e354891 (2012).